| Date Filed | Type | Description |
| 05/11/2023 |
4
| Gosebruch Henry O (Director) has filed a Form 4 on ACELYRIN, Inc.|
Txns:
| Bought 50,000 shares
@ $18, valued at
$900k
Disposed of 155,450 options to buy
@ $7.4345, valued at
$1.2M
Acquired 155,450 options to buy
@ $7.4345, valued at
$1.2M
|
|
| 05/04/2023 |
3
| Gosebruch Henry O (Director) has filed a Form 3 on ACELYRIN, Inc. |
| 05/31/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/20/2022 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 05/20/2022 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 05/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/24/2020 |
4
| Gosebruch Henry O (EVP, Chief Strategy Officer) has filed a Form 4 on AbbVie Inc.|
Txns:
| Sold 6,900 shares
@ $98.83, valued at
$681.9k
Sold 33,100 shares
@ $99.49, valued at
$3.3M
|
|
| 10/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/22/2020 |
4
| Gosebruch Henry O (Director) has filed a Form 4 on Aptinyx Inc.|
Txns:
| Granted 40,000 options to buy
@ $3.84, valued at
$153.6k
|
|
| 04/24/2020 |
4
| Gosebruch Henry O (EVP, Chief Strategy Officer) has filed a Form 4 on AbbVie Inc.|
Txns:
| Gifted 18,500 shares
@ $0
Gifted 18,500 shares
@ $0 |
|
| 04/02/2020 |
4
| Gosebruch Henry O (Director) has filed a Form 4 on Aptinyx Inc.|
Txns:
| Granted 7,374 options to buy
@ $2.16, valued at
$15.9k
|
|
| 03/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/24/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/14/2020 |
4
| Gosebruch Henry O (Director) has filed a Form 4 on Aptinyx Inc.|
Txns:
| Bought 25,000 shares
@ $3, valued at
$75k
|
|
| 01/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/07/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/02/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/16/2019 |
4
| Gosebruch Henry O (EVP, Chief Strategy Officer) has filed a Form 4 on AbbVie Inc.|
Txns:
| Gifted 30,000 shares
@ $0
Gifted 30,000 shares
@ $0 |
|
| 07/31/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/02/2019 |
4
| Gosebruch Henry O (Director) has filed a Form 4 on Aptinyx Inc.|
Txns:
| Granted 2,649 options to buy
@ $3.34, valued at
$8.8k
|
|
| 05/17/2019 |
4
| Gosebruch Henry O (Director) has filed a Form 4 on Aptinyx Inc.|
Txns:
| Granted 80,000 options to buy
@ $3.73, valued at
$298.4k
|
|
| 05/09/2019 |
4
| Gosebruch Henry O (Director) has filed a Form 4 on Aptinyx Inc.|
Txns:
| Bought 3,420 shares
@ $3.75, valued at
$12.8k
Bought 96,580 shares
@ $3.86, valued at
$372.8k
|
|
| 05/07/2019 |
3
| Gosebruch Henry O (Director) has filed a Form 3 on Aptinyx Inc. |
| 03/04/2019 |
4
| Gosebruch Henry O (EVP, Chief Strategy Officer) has filed a Form 4 on AbbVie Inc.|
Txns:
| Paid exercise price by delivering 22,956 shares
@ $79.41, valued at
$1.8M
|
|
| 02/22/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|